Primary Clear Cell Carcinoma of Hilar Bile Duct: A Case Report
Lei Gu,Chun Hui Jiang,Qing Xu,Qiang Liu,Meng Luo,Zhi Yong Wu
DOI: https://doi.org/10.1111/j.1751-2980.2009.00415.x
2010-01-01
Journal of Digestive Diseases
Abstract:Cholangiocarcinoma is a rare tumor accounting for less than 2% of all human malignancies.1 The hilar cholangiocarcinoma (HCC) was first described by Klatskin, and is thus called a Klatskin tumor. HCC is the most common bile tract tumor, accounting for 40% to 60% of these tumors, which affect approximately 7500 Americans each year.2–4 The clear cell cholangiocarcinoma is a variant of HCC and occurs at variable frequencies among large series of HCC. The vacuolated appearance of the tumor cells is due to the cytoplasmic accumulation of a large amount of glycogen or lipids dissolved by routine histological processing. The tumor cells are predominantly or solely composed of cells with a clear cytoplasm that does not stain with hematoxylin–eosin. There is, however, at present no satisfactory explanation of the clear cell tumor development. This rare case of primary clear cell carcinoma of the hilar bile duct is discussed in detail regarding its histological features, with special reference to differential histopathologic diagnosis. Recognition of this unusual variant of bile duct carcinoma will enable surgeons and pathologists to avoid diagnostic confusion with the common type of cholangiocarcinoma and metastatic clear cell carcinoma. A 67-year-old man was admitted to our hospital having experienced symptoms of jaundice for nearly 2 months. Abdominal pain, weakness, weight loss and abdominal mass were absent. The physical examination found severe jaundice of the skin and sclera without significant abdominal physical signs. Laboratory tests revealed abnormal liver function tests reflecting the presence of a biliary obstruction (alanine aminotransferase 166 IU/L, aspartate aminotransferase 137 IU/L, alkaline phosphatase 1430 IU/L, γ-GT 4160 IU/L, total billirubin 113.4 µmol/L and direct biliirubin 90.7 µmol/L). The viral markers of hepatitis B virus and hepatitis C virus were all negative. Tumor markers as CA19-9, alpha fetoprotein and carcinoembryonic antigen were within normal range. Imaging examinations with magnetic resonance cholangiopancreatography (MRCP) and computed tomography (CT) suggested abnormal signals at the hilus of the liver and the mid-superior segment of the common bile duct and were initially considered to be a malignant tumor arising from the biliary duct with intrahepatic cholangiectasis. The CT and MRCP were both negative for masses in the liver or kidneys. During surgery we found that the gallbladder was about 15 cm × 8 cm × 3 cm in size and the para-common hepatic artery lymph nodes and hepatoduodenal ligament lymph nodes were enlarged. About 3000 mL light yellow ascetic fluid was present in the abdominal cavity. The liver manifested the appearance of nodular cirrhosis and cholestasis. The tumor was located at the common hepatic duct and left hepatic duct near the hilus. It had arisen from the left hepatic duct and spread to the common hepatic duct along the left and right hepatic duct. The size of tumor was about 5 cm × 3 cm × 2 cm. There was not much difference observed between it and the common cholangiocarcinoma during the operation. The pathological examination was completed 7 days after the operation. The tissue specimens were fixed in 4% buffered formaldehyde and embedded in paraffin. The sections were routinely stained with haematoxylin–eosin and periodic acid Schiff (PAS). The pathological diagnosis was a special type cholangiocarcinoma, namely, a clear cell adenocarcinoma. Most of the tumor cells were clear with a minority of acidophilic cells (Fig. 1). They were arrayed in alveolate, compact or lamellar patterns. The incipient glandular tubular structure could be seen in some regions. The clear cytoplasm of the tumor cells was abundant, and some had acidophilic particles. The boundary of the cells was distinct and the nucleus was in the center as polygonal or orbicular-ovate anachromasis. Mitotic forms could rarely be seen. An immunohistochemistry investigation showed positive cytokeratin-positive (CK+), CK7++, CK8+++, CK20-, CK19-, Ki-67++ and p53+. The specific PAS stain was also positive. Clear cell cholangiocarcinoma composed mainly of cells with clear cytoplasm (hematoxylin–eosin, original magnification ×100). Clear cell change is a very unusual finding in primary cholangiocarcinoma. It was described firstly by Tyson in 1926, and because of its similar morphology to renal cancer it was named a hypernephroma at that time. In 1992 the World Health Organization considered it to be an individual type, and renamed it clear cell carcinoma of gallbladder and extrahepatic bile duct.5 Although the pathology of HCC has been clarified, the primary clear cell carcinoma is still a rare type of hilar bile duct cancer. It has been reported in only 20 instances in the last 30 years and most cases were clear cell carcinomas of the gallbladder. The largest number of report on clear cell carcinomas of the bile duct was only three6 and studies on this type of cancer are scarce because of its rarity. There is still no satisfactory explanation of the tumor development. It may be due to an accumulation of fat, acidic mucin or distended endoplasmic reticulum. Konishi7 reported that the genesis of the tumor may be associated with neuroendocrine cells. Because of the specific positive expression of CK7 to a single epithelium in classic adenocarcinomas we consider that it may develop sequentially from epithelial metaplasia to dysplasia and then to cancer eventually. The differential diagnosis is mainly between the primary cholangiocarcinoma and renal carcinoma. Hepatic metastasis is usually not the first manifestation of clear cell kidney carcinoma. Currently, the key to differential diagnosis is by preoperative imaging examination, but a divergence of opinions still exists. Vardaman6 reported that clear cell neoplasms of the gallbladder and extrahepatic bile duct must be differentiated from metastatic renal cell carcinoma based upon the presence of areas of conventional adenocarcinoma special stains and immunohistochemistry. Immunohistochemistry plays an important role in distinguishing it from metastatic clear cell carcinoma. The positive expression of CK7 indicated the biliary origin of this tumor. Primary hepatocellular carcinoma and metastatic clear cell carcinoma of the kidney, gastrointestinal tract and thyroid gland were excluded by the absence of CK20, CD10, HepPar1 and TTF1. No mucin could be detected within the cytoplasm of the clear cells. In our case, the presence of positive expression of CK7 and negative expression of CK20 are consistent with those by other studies.8,9 Most doctors believe that there is no significantly different prognosis between clear cell carcinomas and common adenocarcinomas. They also believe that p53 and Ki-67 can indicate the estimation of prognosis. But all the judgments lack valid support in these cases. Unfortunately, our patient died of myocardial infarction 3 days postoperatively, and thus we lost the opportunity of making a follow-up study.